Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-08 | 2023-06-27 | 194097 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-06-27 | 195201 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-08-08 | 2024-11-01 | 234882 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2024-09-05 | 2024-11-01 | 236808 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Actual shortage | 2025-03-13 | 2025-11-20 | 252578 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2025-03-13 | 2025-05-30 | 252581 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2025-05-02 | 2025-06-19 | 256450 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Actual shortage | 2025-11-13 | 2025-12-11 | 271832 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Actual shortage | 2025-11-20 | 2025-12-04 | 272316 |
| TEVA-RANITIDINE | 150MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1510 |
| TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1522 |
| TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1534 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2017-05-23 | 2017-09-19 | 10902 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2018-03-13 | 2018-05-31 | 42626 |
| TEVA-RASAGILINE | 0.5MG | TABLET | Resolved | 2020-01-17 | 2020-06-04 | 103587 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-01-17 | 2020-06-18 | 103590 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-09-17 | 2020-11-26 | 124474 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2021-12-22 | 151445 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162280 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2025-05-08 | 2025-09-25 | 256926 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |